CIK: 1274225 - Address: C/O Quoin Pharmaceuticals Ltd.,, 42127 Pleasant Forest Court, Ashburn,, VA 20148
24 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg
S%ret215-2-5-13-191-1-7
S%wins8060100100505073

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y
6/10/24 16:10
6/7/24
QNRXQuoin Pharmaceuticals, Ltd.L3HealthDrugPharmaceutical PreparationsLanger DennisVADS00.732000-850D
8/5/21 17:11
8/3/21
MYGNMyriad Genetics IncDEHealthDiagnIn Vitro & In Vivo DiagnosticLanger DennisUTDM.d76225.390305090D
8/5/21 17:11
8/3/21
MYGNMyriad Genetics IncDEHealthDiagnIn Vitro & In Vivo DiagnosticLanger DennisUTDS.d-1,04334.750-30-2590D
8/17/18 21:00
8/15/18
DRNADicerna Pharmaceuticals IncDEHealthDrugPharmaceutical PreparationsLanger DennisMADS-61316.000-38-3377M
6/8/18 17:37
6/6/18
MYGNMyriad Genetics IncDEHealthDiagnIn Vitro & In Vivo DiagnosticLanger DennisUTDM.dm43421.2902010540D
6/8/18 17:37
6/6/18
MYGNMyriad Genetics IncDEHealthDiagnIn Vitro & In Vivo DiagnosticLanger DennisUTDS.dm-80239.350-20-3440D
6/5/18 17:45
6/1/18
MYGNMyriad Genetics IncDEHealthDiagnIn Vitro & In Vivo DiagnosticLanger DennisUTDM.dm1,18123.7905040D
6/5/18 17:45
6/1/18
MYGNMyriad Genetics IncDEHealthDiagnIn Vitro & In Vivo DiagnosticLanger DennisUTDS.dm-1,95039.300-50-5640D
6/1/18 16:37
5/30/18
MYGNMyriad Genetics IncDEHealthDiagnIn Vitro & In Vivo DiagnosticLanger DennisUTDM.d24424.390103440D
6/1/18 16:37
5/30/18
MYGNMyriad Genetics IncDEHealthDiagnIn Vitro & In Vivo DiagnosticLanger DennisUTDS.d-37937.920-10-2040D
5/21/18 19:54
5/21/18
MYGNMyriad Genetics IncDEHealthDiagnIn Vitro & In Vivo DiagnosticLanger DennisUTDM.d24424.390103440D
5/21/18 19:54
5/21/18
MYGNMyriad Genetics IncDEHealthDiagnIn Vitro & In Vivo DiagnosticLanger DennisUTDS.d-35935.900-10-2040D
1/30/18 21:30
1/26/18
DRNADicerna Pharmaceuticals IncDEHealthDrugPharmaceutical PreparationsLanger DennisMADM.d13.42000115I
11/17/16 17:01
11/16/16
DRNADicerna Pharmaceuticals IncDEHealthDrugPharmaceutical PreparationsLanger DennisMADS-843.521-24-17115I-63-661-3-26-415-6-10-25-36-37
2/5/16 16:05
2/3/16
DRNADicerna Pharmaceuticals IncDEHealthDrugPharmaceutical PreparationsLanger DennisMADM.d1193.4213533139D-79-70-45-46-49-15-20-3-3-119-28-43-54
2/20/14 15:28
1/27/14
DRNADicerna Pharmaceuticals IncDEHealthDrugPharmaceutical PreparationsLanger DennisMADM.ad303.422091099M110066-59-64-37
12/3/12 16:57
11/29/12
MYGNMyriad Genetics IncDEHealthDiagnIn Vitro & In Vivo DiagnosticLanger DennisUTDM.dm1,25017.8532700D333619145-2-6-60-2-1-1013-3
12/3/12 16:57
11/29/12
MYGNMyriad Genetics IncDEHealthDiagnIn Vitro & In Vivo DiagnosticLanger DennisUTDS.dm-2,09129.8832-70-1000D333619145-2-6-60-2-1-1013-3
2/5/09 16:15
2/5/09
MYGNMyriad Genetics IncDEHealthDiagnIn Vitro & In Vivo DiagnosticLanger DennisUTDM.d40727.153315013-7-23-31-39
2/5/09 16:15
2/5/09
MYGNMyriad Genetics IncDEHealthDiagnIn Vitro & In Vivo DiagnosticLanger DennisUTDS.d-1,24182.7233-15-100013-7-23-31-39
9/8/08 16:29
9/4/08
MYGNMyriad Genetics IncDEHealthDiagnIn Vitro & In Vivo DiagnosticLanger DennisUTDM.dm21521.4933100D149417634-1-3-2-7-21-8-6216
9/8/08 16:29
9/4/08
MYGNMyriad Genetics IncDEHealthDiagnIn Vitro & In Vivo DiagnosticLanger DennisUTDS.dm-64864.7833-10-1000D149417634-1-3-2-7-21-8-6216
12/21/07 11:28
12/19/07
MYGNMyriad Genetics IncDEHealthDiagnIn Vitro & In Vivo DiagnosticLanger DennisUTDM.dm55118.3733300D14457345-21070-3-13-20-134
12/21/07 11:28
12/19/07
MYGNMyriad Genetics IncDEHealthDiagnIn Vitro & In Vivo DiagnosticLanger DennisUTDS.dm-1,42747.5733-30-1000D14457345-21070-3-13-20-134

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact